Description:
MacuMira Medical Devices Inc. presents Canada's first clinically approved treatment for Dry Age-Related Macular Degeneration (AMD). Their unique therapy involves neurostimulation delivered through the eyelid, improving vision without surgery or adverse effects. With a commitment to patient safety and comfort, MacuMira's innovative approach is backed by positive clinical trial results and testimonials, reflecting life-changing benefits for patients with AMD.
Service:
Treatment for Dry Age-Related Macular Degeneration
For more information, please contact us with the following details:
Contact Email:
Support@MacuMira.com
.png){kind=logo}
.png){kind=logo}
Our Network
